The clinical course of trichinellosis is self-limited in most cases, and it is uncomplicated. Mild infections are treated symptomatically with antipyretics and anti-inflammatory agents.

Trichinella infection with systemic complications is treated with antiparasitic agents and corticosteroids.

Albendazole and mebendazole are not considered safe in pregnant women and children less than or equal to 2 years of age. Specialist consultation is necessary in these cases and risk, and weighing the risks versus benefits is necessary before administering these medications. The World Health Organization's recommendations are that pregnant women can get antihelminthic medications (mebendazole, albendazole, pyrantel, or levamisole) after their first trimester.

Cardiac monitoring may necessary for patients with cardiac involvement.

Postexposure prophylaxis with mebendazole if given within 6 days of exposure may be effective.